Search filters

List of works by Satoshi Motoya

A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese population

scientific journal article

Association Study of 71 European Crohnʼs Disease Susceptibility Loci in a Japanese Population

scientific article published on March 1, 2013

C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn's disease

scientific article published on 20 April 2013

Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study

Effects of vedolizumab in Japanese patients with Crohn's disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses

scientific article published on 13 December 2019

Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

scientific article published on 24 December 2013

Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis.

scientific article

Evidence-based clinical practice guidelines for inflammatory bowel disease.

scientific article published on 10 February 2018

First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis-results from a multicenter prospective randomized controlled trial and its post hoc analysis

scientific article published on 11 July 2015

Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis

scientific article

Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries.

scientific article published on 30 April 2018

Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan

scientific article published on 27 April 2016

Sargramostim in patients with Crohn's disease: results of a phase 1-2 study

scientific article published on 8 April 2009

Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies.

scientific article

Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study

scientific article published on 26 February 2019